Impressive results with transthyretin-stabilizer that reduces mortality and hospitalization in patients with transthyretin-related cardiomyopathy

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Long term benefits of antihypertensive and cholesterol-lowering treatment in hypertension
Long term benefits of antihypertensive and cholesterol-lowering treatment in hypertension
ESC 2018
Long term benefits of antihypertensive and cholesterol-lowering treatment in hypertension
- Dr. Ajay Gupta
Women are not a subgroup: the importance of sex-specific analyses
Women are not a subgroup: the importance of sex-specific analyses
ESC 2018
Women are not a subgroup: the importance of sex-specific analyses
- Dr. Jeanine Roeters van Lennep
Surprising result: Association very high levels of HDL-c and increased risk of CV events
Surprising result: Association very high levels of HDL-c and increased risk of CV events
ESC 2018
Surprising result: Association very high levels of HDL-c and increased risk of CV events
- Dr. Marc P Allard-Ratick
Neutral outcomes for early intervention strategy compared to standard strategy in NSTEMI patients
Neutral outcomes for early intervention strategy compared to standard strategy in NSTEMI patients
ESC 2018
Neutral outcomes for early intervention strategy compared to standard strategy in NSTEMI patients
- Prof. Thomas Engstrom